Skip to main content
. 2024 Nov 22;19:1939–1949. doi: 10.2147/CIA.S474209

Table 2.

Comparisons of Laboratory Measurements Between VCI and Control Groups

VCI Group (n=27) Control Group (n=27) χ2/t/Z P
Total cholesterol, mmol/l 4.06 (3.57, 5.36) 4.46 (3.8, 5.62) −1.210 0.226
LDL-C,mmol/l 2.24 (1.96, 3.43) 2.49 (2.21, 3.4) −0.863 0.388
Triglyceride,mmol/l 1.66 (1.11, 2.1) 1.54 (1.02, 1.91) −0.730 0.466
Fasting glucose,mmol/l 5.85 (4.69, 6.89) 5 (4.51, 5.45) −2.042 0.041
Homocysteine,mmol/l 16.15 (12.05, 21.59) 15.5 (11.08, 17.51) −0.801 0.423
FIB,g/l 3.43 (2.69, 4.43) 2.64 (2.35, 3.43) −2.337 0.019
White blood cells,*10–9/l 7.39 (5.71, 8.7) 7.18 (5.61, 8.75) −0.303 0.762
Neutrophils percentage,% 68.72±10.299 68.90±9.604 −0.066 0.948
Serum creatinine,umol/l 82.2 (74.1, 102.8) 85.85 (74.65, 94.1) −0.427 0.669
Uric acid,umol/l 335.6 (274.4, 365.8) 378.1 (327.9, 481.5) −2.473 0.013
IL-6 8.10 (5.98, 14.65) 4.42 (2.47, 5.03) −5.129 0.000
Vsir mRNA in the PBMCs 0.09 (0.07, 0.11) 0.65 (0.14, 5.91) −5.303 0.000
VISTA MFI on intermediate monocytes 1126.5 (884.25, 1658.75) 2884 (2150, 3957.5) −4.180 0.000

Notes: Data are mean value ± SD, n (%) or median [interquartile range].

Abbreviations: LDL-C, low-density lipoprotein cholesterol; IL-6, interleukin-6; MFI, mean fluorescence intensity.